Cannabis use by children and young people

Archives of Disease in Childhood

Volumn 91, Issue 8, 2006, Pages 692-695

  McArdle, P A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

EUPHORIA; HEARING; HUMAN; INTERVENTION STUDY; LEISURE; PLANT; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSOCIAL CARE; REVIEW; SUBSTANCE ABUSE; VISION;

ADOLESCENT; BEHAVIOR THERAPY; CHILD; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; RISK-TAKING; SCHIZOPHRENIA; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33746908178     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2005.071860     Document Type: Review

References (61)

1. http://www.erowid.org/plants/cannabis/cannabis_basics.shtml.
2. Iversen L. Cannabis and the brain. Brain 2003;126(pt 6):1252-70.
3. Nestler EJ, Malenka RC. The addicted brain. Scientific American 2004;290(3):78-85.
4. Prosser J, McArdle P. Secular trends in childhood mental disorder: a review. Psychol Med 1996;26:715-25.
5. Rodham K, Hawton K, Evans E, et al. Ethnic and gender differences in drinking, smoking and drug taking among adolescents in England: a self-report school-based survey of 15 and 16 year olds. J Adolesc 2005;28:63-73.
6. Meltzer H, Gatward R, Goodman R, et al. Mental health of children and adolescents in Great Britain. Office of National Statistics, 2000.
7. Hall W, Swift W. The THC content of cannabis in Australia: evidence and implications. Aust N Z J Public Health 2000;24:503-8.
8. http://www.drugs.gov.uk/publication-search/acmd/cannabis_reclass_2005.
9. Lynskey MT, Heath AC, Bucholz KK, et al. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA 2003;289:427-33.
10. Lynskey M, Vink J, Boomsma D. Early onset cannabis use and progression to other drug use in a sample of Dutch Twins. Behav Genet (in press).
11. McArdle P. Substance abuse by children and young people. Arch Dis Child 2004;89:701-4.
12. McArdle P, Wiegersma A, Gilvarry E, et al. European adolescent substance use: the roles of family structure, function and gender. Addiction 2002;97:329-36.
13. Gilvarry E, Christian J, Crome I, et al. The substance of young needs. Health Advisory Service, 2001.
14. Macleod J, Oakes R, Copello A, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004;363:1579-88.
15. Goodwill RD, Fergusson DM, Horwood LJ. Association between anxiety disorders and substance use disorders among young persons: results of a 21-year longitudinal study. J Psychiatr Res 2004;38:295-304.
16. Viner R, Booy R. Epidemiology of health and illness. BMJ 2005;330:411-14.
17. Fergusson DM, Horwood LJ, Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002;97:1123-35.
18. Ramralcha S, Caspi A, Dickson N, et al. Psychiatric disorders and risky sexual behaviour in young adulthood: cross sectional study in birth cohort. BMJ 2000;321:263-6.
19. Solowij N, Stephens RS, Roffman RA, et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002;287:1123-31.
20. Skosnik PD, Spatz-Glenn L, Park S. Cannabis use is associated with schizotypy and attentional disinhibition. Schizophr Res 2001;48:83-92.
21. Fried P, Watkinson B, James D, et al. Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults. CMAJ 2002;166:887-91.
22. Pope HG Jr, Gruber AJ, Hudson JI, et al. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 2001;58:909-15.
23. Fergusson DM, Horwood LJ, Beautrais AL. Cannabis and educational achievement. Addiction 2003;98:1681-92.
24. Smith A, Fried P, Hogan M, et al. Effects of prenatal marijuana on response inhibition: an fMRI study of young adults. Neurotoxicol Teratol 2004;26:533-42.
25. Fried PA. Adolescents prenatally exposed to marijuana: examinations of facets of complex behaviours and comparisons with the influence of in utero cigarettes. J Clin Pharmacol 2002;42:97s-102s.
26. Zoccolillo M, Vitaro F, Tremblay RE. Problem drug and alcohol use in a community sample of adolescents. J Am Acad Child Adolesc Psychiatry 1999;38:900-7.
27. United Nations General Assembly. Declaration on the guiding principles of drug demand reductions, A/S-20/II. Vienna: United Nations, 1998.
28. Poulton RG, Brooke M, Moffitt TE, et al. Prevalence and correlates of cannabis use and dependence in young New Zealanders. N Z Med J 1997;110:68-70.
29. Fergusson DM, Horwood LJ. Cannabis use and dependence in a New Zealand birth cohort. N Z Med J 2000;113:156-8.
30. Budney AJ, Hughes JR, Moore BA, et al. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry 2004;161:1967-77.
31. Vandrey R, Budney AJ, Kamon JL, et al. Cannabis withdrawal in adolescent treatment seekers. Drug Alcohol Depend 2005;78:205-10.
32. Budney A, Moore B, Vandrey R, et al. The time course and significance of cannabis withdrawal. J Abnormal Psychol 2003;112:393-402.
33. Hussong A, Curran P, Moffitt T, et al. Substance abuse hinders desistance in young adults' antisocial behavior. Dev Psychopathol 2004;16:1029-46.
34. Sidney S, Beck J, Tekawa I, et al. Cannabis and mortality. Am J Public Health 1997;87:585-90.
35. Boros CA, Parsons DW, Zoanetti GD, et al. Cannabis cookies: a cause of coma. J Paediatr Child Health 1996;32:194-5.
36. Arseneault L, Cannon M, Witton J, et al. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004;184:110-17.
37. Smit F, Bolier L, Cuijpers P. Cannabis use and me risk of future schizophrenia. Addiction 2004;99:425-30.
38. Arseneault L, Cannon M, Poulton R, et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002;325:1212-13.
39. Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003;33:15-21.
40. Henquet C, Krabbendam L, Spauwen J, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005;330:11.
41. Stefanis N, Delespaul P, Henquet C, et al. Early cannabis exposure and positive and negative dimensions of psychosis. Addiction 2005;99:1333-41.
42. Zammit S, Allebeck P, Andreasson S, et al. Self-reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002;325:1199-201.
43. Weiser M, Reichenberg A, Rabinowitz J, et al. Self-reported drug abuse in male adolescents with behavioral disturbances, and follow-up for future schizophrenia. Biol Psychiatry 2003;54:655-60.
44. Caspi A, Moffitt T, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-o-methyltransferase gene: longitudinal evidence of a gene × environment interaction. Biol Psychiatry 2005;57:1117-27.
45. Hall W. The psychotogenic effects of cannabis use: challenges in reducing residual uncertainties and communicating the risks. Addiction 2004;99:511.
46. Sporn A, Addington A, Gogtay N, et al. Pervasive developmental disorder and childhood onset schizophrenia: comorbid disorder or a phenotypic variant of a very early onset disease? Biol Psychiatry 2004;55:989-94.
47. Gochman P, Greenstein D, Sporn A, et al. Childhood onset schizophrenia: familial neurocognitive measures. Schizophr Res 2004;71:43-7.
48. McArdle P. Attention-deficit hyperactivity disorder and life-span development. Br J Psychiatry 2004;184:468-9.
49. Heather N. The public health and brief interventions for excessive alcohol consumption: the British experience. Addictive Behaviors 1996;21:857-68.
50. Crawford MJ, Patton R, Touquet R, et al. Screening and referral for brief intervention of alcohol-misusing patients in an emergency department: a pragmatic randomised controlled trial. Lancet 2004;364:1334-9.
51. Waldron HB, Kaminer Y. On the learning curve: the emerging evidence supporting cognitive-behavioral therapies for adolescent substance abuse. Addiction 2004;99(suppl 2):93-105.
52. Liddle H, Dakof G, Parker K, et al. Multidimensional family therapy for adolescent drug abuse: results of a randomized clinical trial. Am J Drug Alcohol Abuse 2001;27:651-88.
53. Dennis M, Godley S, Diamond G, et al. The cannabis youth treatment stud: main findings from two randomised trials. Journal of Substance Abuse Treatment 2004;27:197-213.
54. Jensen PS, Weersing R, Hoagwood KE, et al. What is the evidence for evidence-based treatments? A hard look at our soft underbelly. Mental Health Services Research 2005;7:53-74.
55. Westen D, Novotny CM, Thompson-Brenner H. The empirical status of empirically supported psychotherapies: assumptions, findings, and reporting in controlled clinical trials. Psychol Bull 2004;130:631-63.
56. Hser YI, Evans E, Huang D, et al. Relationship between drug treatment services, retention, and outcomes. Psychiatric Services 2004;55:767-74.
57. Hser YI, Grella CE, Hubbard RL, et al. An evaluation of drug treatments for adolescents in 4 US cities. Arch Gen Psychiatry 2001;58:689-95.
58. Royal College of Paediatrics and Child Health. Bridging the gaps: health care for adolescents. Royal College of Paediatrics and Child Health, 2003.
59. Lawrence DM. Chronic disease care: rearranging the deck chairs. Ann Intern Med 2005;143:458-9.
60. McLellan AT, Lewis DC, O'Brien CP, et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000;284:1689-95.
61. Royal College of Paediatrics and Child Health. Strengthening the care of children in the community. Royal College of Paediatrics and Child Health, 2002.